DOWN-REGULATION OF MIR-203-B IN IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA PATIENTS

被引：0
作者：
Ryabchikova, N. [1 ]
Safuanova, G. [1 ]
Minniakhmetov, I. [2 ]
Karunas, A. [2 ]
Yalaev, B. [2 ]
Shut, E. [2 ]
Latypov, R. [2 ]
Khusnutdinova, E. [2 ]
机构：
[1] Bashkir State Med Univ, Ufa, Russia
[2] UFA, IBG USC RAS, Ufa, Russia
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1733
引用
收藏
页码：686 / 686
页数：1
相关论文
共 50 条
  • [11] Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phase
    Giles, F. J.
    Kantarjian, H. M.
    le Coutre, P. D.
    Baccarani, M.
    Mahon, F-X
    Blakesley, R. E.
    Gallagher, N. J.
    Gillis, K.
    Goldberg, S. L.
    Larson, R. A.
    Hochhaus, A.
    Ottmann, O. G.
    LEUKEMIA, 2012, 26 (05) : 959 - 962
  • [12] QUALITY OF LIFE AND SYMPTOM PROFILE IN PATIENTS WITH IMATINIB-RESISTANT OR -INTOLERANT CHRONIC MYELOID LEUKEMIA
    Ionova, I.
    Nikitina, T.
    Gritsenko, T.
    Ivanova, V.
    Kuchma, G.
    Fedorenko, D.
    Kurbatova, K.
    HAEMATOLOGICA, 2012, 97 : 314 - 314
  • [13] Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phase
    F J Giles
    H M Kantarjian
    P D le Coutre
    M Baccarani
    F-X Mahon
    R E Blakesley
    N J Gallagher
    K Gillis
    S L Goldberg
    R A Larson
    A Hochhaus
    O G Ottmann
    Leukemia, 2012, 26 : 959 - 962
  • [14] Effects of carboxyamidotriazole on in vitro models of imatinib-resistant chronic myeloid leukemia
    Alessandro, Riccardo
    Fontana, Simona
    Giordano, Margherita
    Corrado, Chiara
    Colomba, Paolo
    Flugy, Anna Maria
    Santoro, Alessandra
    Kohn, Elise C.
    De Leo, Giacomo
    JOURNAL OF CELLULAR PHYSIOLOGY, 2008, 215 (01) : 111 - 121
  • [15] Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinib
    Chuah, Charles
    Melo, Junia V.
    ONCOTARGETS AND THERAPY, 2009, 2 : 83 - 94
  • [16] Imatinib-induced apoptosis could be enhanced by Triptolide in Imatinib-resistant chronic myeloid leukemia cell line through down-regulation of HIF-1αand Nrf2
    Xu, Bing
    Chen, Feili
    Liu, Yuejian
    Wang, Shiyun
    Li, Rongwei
    Dong, Huijuan
    Zha, Jie
    BLOOD, 2013, 122 (21)
  • [17] Dasatinib: From Treatment of Imatinib-Resistant or -Intolerant Patients With Chronic Myeloid Leukemia to Treatment of Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
    Abbott, Brian L.
    CLINICAL THERAPEUTICS, 2012, 34 (02) : 272 - 281
  • [18] PATTERNS OF ABL KD MUTATION IN ASIAN PATIENTS WITH IMATINIB-RESISTANT CHRONIC PHASE CHRONIC MYELOID LEUKEMIA
    Kim, H.
    Kim, S.
    Byeun, J.
    Lee, S.
    Kim, H.
    Kim, Yeo-Kyeoung
    Kwak, J.
    Yhim, H.
    Kim, S.
    Do, Y.
    Oh, S.
    Au, W.
    Park, J.
    Jootar, S.
    Kim, D.
    HAEMATOLOGICA, 2013, 98 : 295 - 295
  • [19] Pharmacokinetics of nilotinib in imatinib-resistant/intolerant chronic myeloid leukemia patients on hemodialysis for chronic renal failure
    Onaka, Takashi
    Takahashi, Naoto
    Miura, Masatomo
    Yonezawa, Akihito
    Imada, Kazunori
    Sawada, Kenichi
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (04) : 451 - 451
  • [20] Characteristics of the TCR Vβ repertoire in imatinib-resistant chronic myeloid leukemia patients with ABL mutations
    Ling Xu
    YuHong Lu
    Jing Lai
    Wei Yu
    YiKai Zhang
    ZhenYi Jin
    Yan Xu
    Jie Chen
    XianFeng Zha
    ShaoHua Chen
    LiJian Yang
    YangQiu Li
    Science China Life Sciences, 2015, 58 : 1276 - 1281
12345